インターフェロンによるテオフィリン代謝の抑制
S J Williams1, J A Baird-Lambert, G C Farrell
1Department of Medicine, University of Sydney, NSW, Australia.
Lancet (London, England)
|October 24, 1987
まとめ
再結合インターフェロンアルファAは,慢性的に活発なB型肝炎患者および健康な個体において,テオフィリンクリアランスを有意に低下させた. これは,インターフェロンが薬物代謝に影響を与え,薬物相互作用につながる可能性があることを示唆しています.
科学分野:
- 薬理学 薬理学とは
- 肝臓病理学 肝臓病理学
- 免疫学 免疫学とは
背景:
- インターフェロンは,免疫調節を含む多様な生物学的効果を持つサイトカインです.
- 肝臓の薬物の代謝は,薬物の有効性と安全性にとって極めて重要です.
- 慢性的に活発なB型肝炎は,肝機能と薬物処理に影響を与える可能性があります.
研究 の 目的:
- テオフィリンの薬理動態に対する再結合ヒトインターフェロンアルファAの効果を調査する.
- インターフェロンの効果と基礎理論リン代謝の関係を探求する.
- インターフェロン誘発の薬物相互作用の可能性を評価する.
主な方法:
- 再結合ヒトインターフェロンアルファAの単一の筋肉内注射が投与されました.
- テオフィリンクリアランスとエリミネーション半減期は,慢性的に活発なB型肝炎を患った5人の患者と4人の健康な対照群で測定されました.
- 治療前のおよび治療後の薬理学パラメータを比較した.
主要な成果:
- テオフィリンクリアランスは,インターフェロン投与後1日後に有意に減少しました.
- テオフィリン除去半減期は,インターフェロン投与後に有意に増加した.
- インターフェロンの効果は,テオフィリンを素早く代謝する個体においてより顕著であった.
結論:
- 再結合インターフェロンアルファAは,セオフィリン薬理学を変化させ,クリアランスを低下させ,半減期を延長します.
- 内生インターフェロンは,ウイルス感染症や免疫接種中に観察された肝臓の薬物の代謝の変化に寄与する可能性があります.
- インターフェロン療法は,特に肝臓で代謝される薬剤との臨床的に重要な薬物相互作用のリスクがあります.
関連する概念動画
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...